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Abstract
Objective: To describe outcomes of nonsurgical treatment for symptomatic thumb carpometacarpal joint (CMC-1) instability. Secondary, to
evaluate the conversion rate to surgical treatment.
Design: Prospective cohort study.
Setting: A total of 20 outpatient clinics for hand surgery and hand therapy in the Netherlands.
Participants: A consecutive sample of patients with symptomatic CMC-1 instability (NZ431).
Intervention: Nonsurgical treatment including exercise therapy and an orthosis.
Main Outcome Measures: Pain (visual analog scale [VAS], 0-100) and hand function (Michigan Hand Outcomes Questionnaire [MHQ], 0-100) at
baseline, 6 weeks, and 3 months. Conversion to surgery was recorded for all patients with a median follow-up of 2.8 years (range, 0.8-6.7y).
Results: VAS scores for pain during the last week, at rest, and during physical load improved with a mean difference at 3 months of 17 (97.5%
CI, 9-25), 13 (97.5% CI, 9-18), and 19 (97.5% CI, 12-27), respectively (P<.001). No difference was present at 3 months for MHQ total score, but
the subscales activities of daily living, work, pain, and satisfaction improved by 7 (97.5% CI, 1-14), 10 (97.5% CI, 4-16), 5 (97.5% CI, 2-9), and
12 (97.5% CI, 2-22) points, respectively (P<.001-.007). After median follow-up of 2.8 years, only 59 participants (14%) were surgically treated.
Both in the subgroups that did and did not convert to surgery, VAS pain scores decreased at 3 months compared with baseline (P<.001-.010),
whereas MHQ total score did not improve in both subgroups. However, VAS and MHQ scores remained worse for patients who eventually
converted to surgery (P<.001).
Conclusions: In this large sample of patients with symptomatic CMC-1 instability, nonsurgical treatment demonstrated clinically relevant im-
provements in pain and aspects of hand function. Furthermore, after 2.8 years, only 14% of all patients were surgically treated, indicating that
nonsurgical treatment is a successful treatment of choice.
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ª 2019 by the American Congress of Rehabilitation MedicineSymptomatic thumb carpometacarpal joint (CMC-1) instability
can arise from multiple causes, such as generalized hypermobility,
congenital disorders, or trauma and may cause pain and limita-
tions in activities of daily living (ADL).1-4 Furthermore, it has
been suggested in literature that CMC-1 instability may predis-
pose CMC-1 to osteoarthritis (OA) later in life.5-10Supported by Handtherapie Nederland, Xpert Clinic, and Erasmus MC.
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https://doi.org/10.1016/j.apmr.2019.08.485Whereas multiple studies have investigated nonsurgical treat-
ment for CMC-1 OA.11-15 to our knowledge, there are no studies
describing outcome of nonsurgical treatment for symptomatic
CMC-1 instability. Similar to patients with CMC-1 OA, orthotics
and exercise programs may provide a long-term solution by
improving lifestyle, joint mechanics, and function, but evidence for
their effectiveness in symptomatic CMC-1 instability is lacking.11-15
Exercise therapy for CMC-1 instability intends to improve
active stability and positioning of the CMC-1 into a more stable
position of extension/abduction because the CMC-1 is less stablehabilitation Medicine
2 R.M. Wouters et alduring flexion/adduction.6,8-10,16-18 Additionally, exercise therapy
aims to maintain the first web space and improve thumb pinch
strength.3,6,12,17,18 Furthermore, (temporary use of) orthotics often
complement exercise therapy to reduce subluxation and inflam-
mation.6,12 Theoretically, improving joint mechanics in patients
with CMC-1 instability might be very beneficial because CMC-1
instability may precede CMC-1 OA later in life.5-10
In cases of symptomatic CMC-1 instability where insufficient
improvement occurs following nonsurgical treatment, surgical
stabilization of the CMC-1 joint can be considered.2,19,20 How-
ever, the outcome of these procedures are not very predictable,
and it has been reported that results of these surgical procedures
are unsatisfactory in 12%-55%.2,19 In addition, surgical treatment
comes with long recovery, prolonged patient discomfort and
limitations, and high costs.21-23 Hence, because nonsurgical
treatment potentially has many advantages compared with surgical
treatment and because no studies are available on this topic, more
research on nonsurgical treatment for CMC-1 instability is
needed. Therefore, the aim of this study is to describe the out-
comes of nonsurgical treatment, exercise therapy, and an orthosis
for symptomatic CMC-1 instability. Secondary, the objective was
to evaluate the conversion rate to surgical treatment.Methods
Study design
This is a prospective cohort study using a consecutive, population-
based sample reported following the Strengthening the Reporting
of Observational Studies in Epidemiology statement.24
Setting
Data were collected at Xpert Clinic and Handtherapie Nederland,
comprising 20 outpatient clinics for hand surgery and therapy in
the Netherlands, and took place between January 2012 and
September 2018 after approval by the local Medical Research
Ethical Committee. Data collection was part of routine outcome
measurement using GemsTrackera electronic data capture tools.
GemsTracker (GEneric Medical Survey Tracker) is a secure web-
based application for distribution of questionnaires and forms
during clinical research and quality registrations; details have been
published earlier.11,15,25
Participants
All patients were initially diagnosed as having CMC-1 instability
by one of the certified hand surgeons by physical examination.
Radiographic evaluation of the CMC-1 joint was not systemati-
cally performed, but radiographs were obtained if CMC-1 OAwas
suspected. Subsequently, patients were referred for hand therapy.
Follow-up with the hand surgeon took place after 3 months to
decide if additional treatment was needed. For this study, we
excluded patients who (1) were diagnosed as having CMC-1 OAList of abbreviations:
ADL activities of daily living
CMC-1 thumb carpometacarpal joint
MHQ Michigan Hand Outcomes Questionnaire
OA osteoarthritis
VAS visual analog scale(including radiographic confirmation), (2) had comorbidity inter-
fering with treatment and/or outcome (ie, de Quervain’s teno-
synovitis), (3) had a patient history includes surgery interfering
with treatment and/or outcome, or (4) received a steroid injection
<6 weeks ago in hand or wrist.
Treatment
The treatment in this study was not completely standardized as in
randomized controlled trials because data collection was part of
usual care. However, treatment by the hand therapists was carried
out using a strict guideline,26 which prescribes the use of both
exercises and orthotics when needed. The exercises and orthotics
were not applied in every patient because the treatment was
tailored to the patient’s needs and based on a shared decision-
making process (eg, influenced by patient preferences, therapy
costs, and traveling distance).
If an orthosis was provided, this included a static orthosis to
reduce synovitis and instability.12,27 The orthosis was custom
made and thermoplastic; it immobilized the CMC-1 in extension/
abduction and the first metacarpophalangeal joint in slight flexion.
The exercise program included hand therapy sessions and exer-
cises performed by the patient at home. These exercises aimed to
improve the active stability of the thumb during pinch in exten-
sion/abduction because flexion/adduction causes instability and
eventually degeneration.3,6,8-10,18 In the first 6 weeks, the exercises
aimed to improve coordination of the intrinsic thenar muscles
(except the adductor pollicis), extensor pollicis brevis, and the first
dorsal interosseous.3,6,11,18 Because of the observational design of
this study, no strict prescriptions regarding orthotic use were
provided, but in general, if an orthosis was applied, participants
were instructed to use it during heavy and provocative activities.
Guided by the hand therapist, orthosis use was reduced in the
subsequent 6 weeks. Furthermore, strengthening exercises for the
thenar muscles (except adductor pollicis) were initiated in this
phase in addition to the coordination exercises.3,6,11,18Variables, data sources/measurement
Primary and secondary outcomes
Primary outcomes in this study were pain and hand function at 3
months. Mean pain in the last week, pain at rest, and pain during
physical load were measured at baseline, 6 weeks, and 3 months
using a visual analog scale (VAS; range, 0-100; higher scores
indicate more pain). The VAS is a widely used, reliable, and valid
tool for measuring pain intensity and has a minimal clinically
important difference of 11 points.28 Hand function at baseline and
3 months was evaluated using the Michigan Hand Outcomes
Questionnaire (MHQ).29 We used the MHQ total score as primary
outcome while its 6 subscales were secondary outcomes (range, 0-
100; higher scores indicate better performance except for the
subscale pain).29 The MHQ is a widely used tool for measuring
hand function and has a high internal consistency, high internal
validity, and acceptable reliability.29 The MHQ has a minimal
clinically important difference of 8-13 points (3-23 for the sub-
scales).30,31 Additional measurements included patient satisfaction
at 6 weeks, 3 months, and 12 months, assessed using a self-
designed questionnaire on the perceived treatment effect and the
patients’ willingness to undergo the treatment again. Conversion
to surgery within a median follow-up of 2.8 years (range,
0.8-6.7y) was derived from patient charts and additional ques-
tionnaires distributed 1 year after start of nonsurgical treatment. Ifwww.archives-pmr.org
Non-surgical treatment in thumb instability 3a patient converted to surgery, we measured the time in months
between the start of the nonsurgical treatment and the decision to
proceed to surgical treatment.
Additional variables that were routinely collected in our
database at baseline included age, sex, type of work, symptom
duration, treatment side, and dominance (table 1).
Study size
Power analysis for a repeated measures design with 2 primary
outcomes using a conventional medium effect size of 0.15
(defined by Cohen32), aZ0.025, and a power of 0.80 showed that
a total sample of 87 participants was needed, which was well
below the sample of 435 participants that we were able to include.
Statistical methods
At baseline, 62%-72% of the primary outcomes were available. If
there were missing data, we checked whether it could be retrieved
from patient charts. Missing value analysis for outcomes at 3
months demonstrated a nonsignificant Little’s test (PZ.771),
which suggested that missing values were missing completely at
random.33-35 To further evaluate missing data at 3 months, sig-
nificance testing on demographic characteristics and baseline
primary outcomes was performed to compare participants with the
presence of a primary outcome at 3 months with participants
without the presence of a primary outcome at 3 months. No sig-
nificant differences between participants with and without the
presence of a primary outcome at 3 months were found
(supplemental table S1, available online only at http://www.
archives-pmr.org/). Because the data were missing completely at
random and no differences between participants with and without
the presence of a primary outcome at 3 months were present, we
used multiple imputation to obtain missing data for continuous
variables with <75% missing.33,36,37
Treatment outcomes were analyzed using univariate linear
mixed model analyses, using the outcome of interest as a depen-





Age, mean  SD (y) 38.213
Female sex (%) 80








Type of work (%)
- Unemployed 18
- Light physical labor 32
- Moderate physical labor 36
- Heavy physical labor 14
Second opinion (%) 9
www.archives-pmr.orgchecked using residual plots and normal probability plots. The
threshold for significance is lowered to .025 from a conventional
.05 to correct for multiple testing.
In addition to the overall treatment effect in the entire sam-
ple, we performed subgroup analysis for the patients who
eventually converted to surgery, again using linear mixed
model analyses.Results
Pain, hand function, and satisfaction with
treatment result
A total of 462 participants were screened for eligibility, and 431
participants were included after applying the eligibility criteria.
From the excluded participants, 26 participants received an in-
jection, 1 had comorbidity (de Quervain’s tenosynovitis), and 4
had recurrent CMC-1 instability following previous surgery
(fig 1). VAS scores for pain during the last week, pain at rest, and
pain during physical load improved with mean differences at 3
months of 17 (97.5% CI, 9-25), 13 (97.5% CI, 9-18), and 19
(97.5% CI, 12-27) points, respectively (P<.001) (fig 2). Figure 3
demonstrates the distribution of VAS pain during physical load
at baseline and 3 months, indicating large variability in pain levels
both prior to and after treatment. However, fig 4 shows the course
of VAS pain during physical load over time for 4 quartiles of
baseline pain levels, indicating that higher baseline pain during
physical load not necessarily leads to more pain at follow-up.
For theMHQ total score, no significant differencewas present at
3 months, but the MHQ subscales ADL, work performance, pain,
and satisfaction with hand function improved compared with
baseline (P<.001-.007) (table 2). No significant changeswere found
in the MHQ subscales overall hand function and aesthetics. At 3
months, 83% of the participants would consider to undergo the
nonsurgical treatment again under similar circumstances (table 2).
Conversion to surgery
Figure 5 shows the survival curve for conversion to surgery,
indicating that after a median follow-up of 2.8 years, 59 partici-
pants (14%) converted to surgical treatment. For the participants
who converted to surgical treatment, median time to make the
decision to convert to surgery was 3.4 months (range, 1-37mo)
after the start of the nonsurgical treatment. Figures 6A-B
demonstrate the difference between patients who eventually did or
did not convert to surgery regarding the development of VAS pain
during physical load and MHQ total score, respectively. When
analyzing the course of VAS pain during physical load separately
for participants who did and did not convert to surgical treatment
eventually, both subgroups demonstrated decreased pain levels at
3 months compared with baseline (P<.001-.010). For MHQ total
score, no significant improvement was achieved in both subgroups
(PZ.046-.152). However, patients who converted to surgery
overall reported worse VAS and MHQ total scores than patients
who did not convert to surgery (see fig 6A-B) (P<.001).
Furthermore, there was an interaction between subgroup and
change in VAS or MHQ score over time, indicating that patients
who converted to surgery demonstrated less improvement in VAS
and more improvement in MHQ score over time than patients who
did not convert to surgery (P<.001).
Fig 1 Flowchart of the study.
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We found a clinically relevant decrease in pain for patients treated
nonsurgically for symptomatic CMC-1 instability. Furthermore,
only 14% of the patients were surgically treated after a median
follow-up of 2.8 years. In addition, improvements were found in
secondary outcomes for ADL, work performance, and satisfaction
with hand function. Additionally, our subgroup analysis indicatedFig 2 VAS (range, 0-100; higher scores represent more pain) scores for p
weeks, and 3 months. Linear mixed model analysis demonstrated that pain
at 3 months compared with baseline (P<.001). Group means and standarthat for patients who eventually converted to surgery, there still
was a clinically relevant decrease in pain scores despite the de-
cision to proceed to surgical treatment. However, both pain and
hand function scores remained worse over time in the subgroup
that converted to surgery compared with those who did not convert
to surgery.
To our knowledge, this is the first study reporting outcomes for
nonsurgical treatment for symptomatic CMC-1 instability; hence,
we cannot compare our results with previous studies. Because our
study indicates clinically relevant improvement in patient-reported
outcome measures and surgical treatment may lead to unsatis-
factory results,2,19 it is highly recommended that nonsurgical
treatment for symptomatic CMC-1 instability is considered as a
primary treatment of choice in patients with CMC-1 instability.
This is especially the case because nonsurgical treatment for
CMC-1 instability is aiming to improve lifestyle, joint mechanics,
and function and might therefore prevent or at least delay the
development of CMC-1 OA in later life because CMC-OA might
be a result of CMC-1 instability.5-10 However, because we did not
evaluate the disease course over a longer period of time in this
study, future studies should investigate if nonsurgical treatment for
CMC-1 instability has a preventive effect in CMC-1 OA
development.
When analyzing the subgroup of patients with CMC-1
instability who eventually converted to surgery, we found a
clinically relevant decrease in pain scores at 3 months
compared with baseline scores. This decrease in pain levels
over time is in contrast to findings by Tsehaie et al,15 who
found that in patients with CMC-1 OA who eventually con-
verted to surgery, pain levels did not change over time. Inain physical load, mean pain last week, and pain at rest at baseline, 6
during physical load, mean pain last week, and pain at rest decreased
d errors are plotted.
www.archives-pmr.org
Fig 3 Overall distribution of the entire sample for VAS during physical load (range, 0-100; higher scores represent more pain) at baseline and 3
months after nonsurgical treatment, displaying the number of patients per 10-point intervals in VAS score.
Non-surgical treatment in thumb instability 5another study, Tshaie et al38 found that the decision to undergo
surgical treatment strongly depends on a change in pain levels
during nonsurgical treatment. Our findings suggests that in
patients with CMC-1 instability this is not the case, and the
decision to undergo surgery might depend on higher residual
pain levels and not on change in pain score over time. This is
supported by our finding that while pain levels decreased in the
subgroup that converted to surgery, pain levels and hand
function scores remained worse than those of the subgroup of
patients who did not convert to surgery. However, future
studies using prediction models in patients with CMC-1
instability are needed to validate this hypothesis.Fig 4 Course over time for VAS (range, 0-100; higher scores represent m
load, indicating that patients with higher baseline pain demonstrate the la
little improvement. Subgroup means and standard errors are plotted.
www.archives-pmr.orgAnother remarkable finding is that, in general in our sample,
we found a relatively large variability in outcomes. For example,
we found that while 83% of the patients would undergo the same
treatment again, 17% would not. Further, we found large variation
in pain levels both prior to treatment and 3 months after treatment.
However, whereas some studies report that higher baseline pain
predicts higher residual pain in patients with CMC-1 OA,11,14 our
study also indicates that this pattern might be otherwise in patients
with CMC-1 instability. These findings indicate that while the
majority of patients respond well to this nonsurgical treatment,
some patients do not. Hence, future studies need to investigate
factors that contribute to this variability in outcome.ore pain), categorized by quartiles for baseline pain during physical
rgest improvement and patients with lower baseline pain demonstrate
Table 2 Outcomes for MHQ (score range 0-100, higher scores indicate better performance except for the pain subscale) at baseline and 3
months and patient satisfaction at 3 months following nonsurgical treatment
Variable Baseline 3 mo
Mean Difference
Baseline3 mo (97.5% CI) P Value
Total MHQ, mean  SD 60.7  14.1 64.8  18.9 4.2 (2 to 11) .036
MHQ subscales, mean  SD:
- Overall hand function 57.6  17.7 60.2  25.6 2.6 (2 to 8) .154
- ADL 62.3  23 69.7  26.7 7.4 (1-14) <.001*
- Work performance 53.3  26 63.1  23.8 9.8 (4-16) <.001*
- Pain (higher scores indicate more pain) 36.9  24.2 31.6  14.5 5.2 (2-9) .007*
- Aesthetics 81.9  19.2 72  28.9 9.9 (5 to 25) .096
- Satisfaction with hand function 43.3  20.5 55.7  34.3 12.4 (2-22) <.001*






Participants who would undergo treatment again (%) 83
NOTE. Significance testing for mean differences in MHQ at 3 months was performed using linear mixed model analysis.
* P<.025.
6 R.M. Wouters et alStudy limitations
A strength of this study is that this is, to our knowledge, the first
study reporting outcomes of nonsurgical treatment for CMC-1Fig 5 Survival curve displaying the number of patients who converted to
converting to surgery, and the x-axis represents the time in months after s
the nonsurgical treatment (range of conversion, 1-37mo), 14% decided tinstability. Furthermore, we were able to evaluate a large group of
431 using standardized patient-reported outcome measures.
However, there are also a number of limitations. First, a limitation
of this study is its observational character. Despite standardizationsurgery over time. The y-axis represents the percentage of patients not
tart of treatment. After a median time of 3.4 months after the start of
o convert to surgery.
www.archives-pmr.org
Fig 6 VAS (range, 0-100; higher scores represent more pain [A]) score for pain during physical load and MHQ (range, 0-100; higher scores
represent better function [B]) separately for participants who converted to surgery (nZ59, 14%) and participants who did not convert to surgery
(nZ372, 86%). Linear mixed model analysis demonstrated that pain during physical load decreased in both participants who did (PZ.010) or did
not convert to surgery at 3 months compared with baseline (P<.001). For MHQ total score, no significant improvement was achieved in both
subgroups (PZ.046-.152). However, both pain and hand function levels were worse for patients who eventually converted to surgery (P<.001).
Moreover, there was an interaction between subgroup and change in pain or hand function scores over time (P<.001). VAS scores during rest and
VAS last week demonstrated the same pattern as VAS during physical load. Group means and standard errors are plotted.
Non-surgical treatment in thumb instability 7of treatment using strict protocols and standardized procedures for
data collection, inherent to observational studies, the actual pro-
vided treatment might have deviated from the treatment protocols.
For example, the exercises and orthotics might not have been
applied in every patient. However, in contrast to a randomized
controlled trial setting, an advantage of our observational study
design is that the results are highly representative for actual
daily practice.
An additional limitation of this study is that the present study
does not allow evaluation of separate treatment effects of exercise
therapy or the use of orthoses in CMC-1 instability. While the
exercise therapy aims to improve joint mechanics, active stability,
and strength, and the orthosis aims to reduce subluxation and
inflammation, it is unknown if combining this treatment with or-
thoses is useful. Hence, future studies should investigate the long-
term outcomes for these different nonsurgical treatments for
CMC-1 instability separately in a more standardized setting.
Another limitation of this study is the amount of missing data
and the need for multiple imputation. However, our nonresponder
analyses and the nonsignificant Little’s test give us confidence that
our outcomes represent the target population.
Furthermore, a limitation of this study is that the percentage of
conversion to surgery that we report might be an underestimation
because, despite our efforts to follow our patients over time, a
patient might have been surgically treated elsewhere. Hence, this
percentage of patients converting to surgery following nonsurgical
treatment for CMC-1 instability needs validation in future pro-
spective research.Conclusions
In conclusion, patients treated nonsurgically for symptomatic
CMC-1 instability showed a clinically relevant decrease in pain
and improvement in secondary outcomes such as ADL, work
performance, and satisfaction with hand function. Furthermore,www.archives-pmr.orgonly 59 of all 431 patients (14%) converted to surgery after a
median follow-up of 2.8 years, indicating this nonsurgical treat-
ment is a successful treatment of choice, although we found large
variation in pain levels. Future studies should investigate predic-
tive factors that contribute to this variability in outcome following
nonsurgical treatment for CMC-1 instability.Supplier
a. GEneric Medical Survey Tracker version 1.8.2; Erasmus MC
and Equipe Zorgbedrijven.Keywords
Carpometacarpal joints; Ehlers-Danlos Syndrome; Exercise
therapy; Joint instability; Orthotic devices; Physical therapy
modalities; Rehabilitation; Thumb
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